Frontlight ResearchEarly access
Alzheimer disease trials in Denmark
4 of 8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Where
- Aalborg, Aarhus N, København Ø
- Age
- 50 years to 90 years
- People
- 80,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07177352 - Phase 2Not yet taking people in DenmarkStudy to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
- Where
- Aalborg, Aarhus N, Copenhagen Oe
- Age
- 50 years to 90 years
- People
- 450 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781657 · EU 2026-526158-14-00 - Phase 3Not yet taking people in DenmarkA study to learn about the effects of Trontinemab in participants at risk for Alzheimer‘s disease
- Where
- Aalborg, Aarhus N, Copenhagen Oe
- Age
- 18 years and over
- People
- 119 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2025-524314-29-00 - No phaseTaking peopleStudy on the Effect of 40 Hz Non-Invasive Light Therapy System
- Where
- Roskilde
- Age
- 40 years and over
- People
- 62
- Run by
- Zealand University Hospital
See details and how to joinNCT05260177